Government Briefs

Calling All Industry Scientists NSF has selected 47 scientists to spend several months doing research in Japan under three new fellowship programs designed to even out the flow of knowledge between the two countries. But while the Japanese-funded programs are open to any qualified scientist, everyone in the first batch hails from either a university or government laboratory. “The lack of participation by industry has been a real disappointment,” admits NSF,s Charles (“TomR

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

NSF has selected 47 scientists to spend several months doing research in Japan under three new fellowship programs designed to even out the flow of knowledge between the two countries. But while the Japanese-funded programs are open to any qualified scientist, everyone in the first batch hails from either a university or government laboratory. “The lack of participation by industry has been a real disappointment,” admits NSF,s Charles (“Tom”) Owen. “About 6% of the 5,000 inquiries we received came from industry, but none of them actually applied.” Likewise, none of the U.S. scientists has been placed in Japanese industrial labs. NSF officials aren’t sure why the participation skewed toward academia. But they admit that participation requires U.S. scientists to become more flexible. “The point of the program is to make opportunities available, as painlessly as possible, for Americans to live and work in Japan,” Owen says. “If we have to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies